17 July 2024
Scientific organizations in Russia have developed candidate flu vaccine viruses to prevent H5N1 avian flu in humans, according to the press service of Rospotrebnadzor. The decision to develop these medications was made based on recommendations from the WHO.
Agency representatives have also emphasized that Rospotrebnadzor is actively monitoring the health of individuals working with poultry. They have developed and implemented regulatory documents for veterinarians and healthcare workers to guide their actions in the event of bird flu detection.
This aims to prevent the further spread of the infection among animals and humans.
PrintNovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
16 May 2024
06 September 2024
HPV vaccine is to be included in Russia’s national immunization schedule by 2026
06 September 2024
New WHO guidance to support manufacturers to reduce AMR risk
05 September 2024
05 September 2024